MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fate Therapeutics (FATE) Earnings Date & Reports
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
FATE is expected to report earnings to rise 17.44% to -29 cents per share on March 01
Q4'26
Est.
$-0.29
Q3'26
Beat
by $0.02
Q2'26
Beat
by $0.02
Q1'26
Beat
by $0.02
Q4'25
Est.
$-0.27
The last earnings report on November 05 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 1.29M shares outstanding, the current market capitalization sits at 219.87M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
What Are the Key Strategies for Success in Futures and Commodities Trading?
AI Robots: Top 10 Trend Traders,Virtual Accounts, on September 23, 2024
The Art of Stock Trading: Price Action and Market Correlations
Channel Stock Patterns: Achieving 69-88% Win Rate
What Are the Key Factors That Drive Exchange Rate Fluctuations?
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com